Recent studies suggest that GLP-1 (9–36), the metabolite that is generated by DPP-4 and 1000-fold lower affinity to GLP-1R [46], also improve LV contractile function and post-ischemic myocardial injury [47]. The gene discussed is DPP4; the disease is injury.